According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in ...
Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...
As the scope of proteomics is extremely broad, it is helpful to distinguish among its various aspects before discussing how microarray technology is likely to feature. Over the past decade, the ...
Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...
Exploration means looking around, observing, describing and mapping undiscovered territory, not testing theories or models. The goal is to discover things we neither knew or expected, and to see ...
PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...
StockStory.org on MSN

3 mid-cap stocks that concern us

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and genome ...